|
1
|
Link MP, Goorin AM, Miser AW, Green AA,
Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick
JA, et al: The effect of adjuvant chemotherapy on relapse-free
survival in patients with osteosarcoma of the extremity. N Engl J
Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luu HH, Zhou L, Haydon RC, Deyrup AT,
Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA, et al:
Increased expression of S100A6 is associated with decreased
metastasis and inhibition of cell migration and anchorage
independent growth in human osteosarcoma. Cancer Lett. 229:135–148.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalamaga M: Nicotinamide
phosphoribosyl-transferase/visfatin: A missing link between
overweight/obesity and postmenopausal breast cancer? Potential
preventive and therapeutic perspectives and challenges. Med
Hypotheses. 79:617–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hufton SE, Moerkerk PT, Brandwijk R, de
Bruïne AP, Arends JW and Hoogenboom HR: A profile of differentially
expressed genes in primary colorectal cancer using suppression
subtractive hybridization. FEBS Lett. 463:77–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Folgueira MA, Carraro DM, Brentani H,
Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares
FA, Oliveira CT, et al: Gene expression profile associated with
response to doxorubicin-based therapy in breast cancer. Clin Cancer
Res. 11:7434–7443. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bi TQ and Che XM: Nampt/PBEF/visfatin and
cancer. Cancer Biol Ther. 10:119–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haslehurst AM, Koti M, Dharsee M, Nuin P,
Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, et al: EMT
transcription factors snail and slug directly contribute to
cisplatin resistance in ovarian cancer. BMC Cancer. 12:912012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rosanò L, Cianfrocca R, Spinella F, Di
Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG and Bagnato
A: Acquisition of chemoresistance and EMT phenotype is linked with
activation of the endothelin A receptor pathway in ovarian
carcinoma cells. Clin Cancer Res. 17:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang XC, Chen JQ and Li B: Salvianolic
acid A suppresses CCL-20 expression in TNF-α-treated macrophages
and ApoE-deficient mice. J Cardiovasc Pharmacol. 64:318–325. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bae KM, Parker NN, Dai Y, Vieweg J and
Siemann DW: E-cadherin plasticity in prostate cancer stem cell
invasion. Am J Cancer Res. 1:71–84. 2011.PubMed/NCBI
|
|
12
|
Pon YL, Auersperg N and Wong AS:
Gonadotropins regulate N-cadherin-mediated human ovarian surface
epithelial cell survival at both post-translational and
transcriptional levels through a cyclic AMP/protein kinase A
pathway. J Biol Chem. 280:15438–15448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li B, Dong Z, Liu H, Xia YF, Liu XM, Luo
BB, Wang WK, Li B, Gao F, Zhang C, et al: Serum amyloid A
stimulates lipoprotein-associated phospholipase A2 expression in
vitro and in vivo. Atherosclerosis. 228:370–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Z, Wu MS, Zou C, Tang Q, Lu J, Liu D,
Wu Y, Yin J, Xie X, Shen J, et al: Downregulation of MCT1 inhibits
tumor growth, metastasis and enhances chemotherapeutic efficacy in
osteosar-coma through regulation of the NF-κB pathway. Cancer Lett.
342:150–158. 2014. View Article : Google Scholar
|
|
16
|
Li Y, Zhang ZN, Zhao HM, Tong ZC, Yang J,
Wang H and Liang XJ: Matrine inhibits the invasive properties of
human osteosarcoma cells by downregulating the ERK-NF-κB pathway.
Anticancer Drugs. 25:1035–1043. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang G, Yuan J and Li K: EMT transcription
factors: Implication in osteosarcoma. Med Oncol. 30:6972013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
PosthumaDeBoer J, Witlox MA, Kaspers GJ
and van Royen BJ: Molecular alterations as target for therapy in
metastatic osteosarcoma: A review of literature. Clin Exp
Metastasis. 28:493–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krishnan K, Khanna C and Helman LJ: The
biology of metastases in pediatric sarcomas. Cancer J. 11:306–313.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harting MT and Blakely ML: Management of
osteosarcoma pulmonary metastases. Semin Pediatr Surg. 15:25–29.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khan JA, Tao X and Tong L: Molecular basis
for the inhibition of human NMPRTase, a novel target for anticancer
agents. Nat Struct Mol Biol. 13:582–588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang T, Zhang X, Bheda P, Revollo JR, Imai
S and Wolberger C: Structure of Nampt/PBEF/visfatin, a mammalian
NAD+ biosynthetic enzyme. Nat Struct Mol Biol.
13:661–662. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SR, Bae SK, Choi KS, Park SY, Jun HO,
Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, et al: Visfatin promotes
angiogenesis by activation of extracellular signal-regulated kinase
1/2. Biochem Biophys Res Commun. 357:150–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reddy PS, Umesh S, Thota B, Tandon A,
Pandey P, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V,
Rao MR, et al: PBEF1/NAmPRTase/Visfatin: A potential malignant
astrocytoma/glioblastoma serum marker with prognostic value. Cancer
Biol Ther. 7:663–668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Van Beijnum JR, Moerkerk PT, Gerbers AJ,
De Bruïne AP, Arends JW, Hoogenboom HR and Hufton SE: Target
validation for genomics using peptide-specific phage antibodies: A
study of five gene products overexpressed in colorectal cancer. Int
J Cancer. 101:118–127. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Patel ST, Mistry T, Brown JE, Digby JE,
Adya R, Desai KM and Randeva HS: A novel role for the adipokine
visfatin/pre-B cell colony-enhancing factor 1 in prostate
carcinogenesis. Peptides. 31:51–57. 2010. View Article : Google Scholar
|
|
27
|
Nakajima TE, Yamada Y, Hamano T, Furuta K,
Gotoda T, Katai H, Kato K, Hamaguchi T and Shimada Y: Adipocytokine
levels in gastric cancer patients: Resistin and visfatin as
biomarkers of gastric cancer. J Gastroenterol. 44:685–690. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakajima TE, Yamada Y, Hamano T, Furuta K,
Matsuda T, Fujita S, Kato K, Hamaguchi T and Shimada Y:
Adipocytokines as new promising markers of colorectal tumors:
Adiponectin for colorectal adenoma, and resistin and visfatin for
colorectal cancer. Cancer Sci. 101:1286–1291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesen-chymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014.PubMed/NCBI
|
|
30
|
Yang H, Zhang Y, Zhou Z, Jiang X and Shen
A: Snail-1 regulates VDR signaling and inhibits
1,25(OH)-D3 action in osteosarcoma. Eur J Pharmacol.
670:341–346. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Larriba MJ, Ordóñez-Morán P, Chicote I,
Martín-Fernández G, Puig I, Muñoz A and Pálmer HG: Vitamin D
receptor deficiency enhances Wnt/β-catenin signaling and tumor
burden in colon cancer. PLoS One. 6:e235242011. View Article : Google Scholar
|
|
32
|
Stubbins RE, Hakeem A and Núñez NP: Using
components of the vitamin D pathway to prevent and treat colon
cancer. Nutr Rev. 70:721–729. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishimura A, Akeda K, Matsubara T,
Kusuzaki K, Matsumine A, Masuda K, Gemba T, Uchida A and Sudo A:
Transfection of NF-κB decoy oligodeoxynucleotide suppresses
pulmonary metastasis by murine osteosarcoma. Cancer Gene Ther.
18:250–259. 2011. View Article : Google Scholar
|
|
34
|
Huber MA, Azoitei N, Baumann B, Grünert S,
Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is
essential for epithelial-mesenchymal transition and metastasis in a
model of breast cancer progression. J Clin Invest. 114:569–581.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelial-mesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM,
Zhou HX, Jia G, Wang YW, Kong R, Pan SH, et al: Nuclear
factor-κB-dependent epithelial to mesenchymal transition induced by
HIF-1α activation in pancreatic cancer cells under hypoxic
conditions. PLoS One. 6:e237522011. View Article : Google Scholar
|
